Vimarsana
Biggest News Aggregation in the World

Page 38 - Icon Plc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Icon Plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Icon Plc Today - Breaking & Trending Today

ICON Clinical Research faces ERISA complaint over 401(k) plan management - Vimarsana News

ICON Clinical Research faces ERISA complaint over 401(k) plan management

ICON Clinical Research faces ERISA complaint over 401(k) plan management Getty Images Former employees of ICON Clinical Research LLC, North Wales, Pa., sued the company and fiduciaries alleging mismanagement of a company 401(k) plan violated their duties under ERISA. "The plan had substantial bargaining power regarding the fees and expenses that were charged against participants' investments," said the March 26 complaint filed in U.S. District Court in Philadelphia. "Defendants, however, did not try to reduce the plan's expenses or exercise appropriate judgment to scrutinize each investment o...

Global Pharma Clinical Trial Services Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Market Forecasts, Analysis 2021-2025 - Vimarsana News

Global Pharma Clinical Trial Services Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Market Forecasts, Analysis 2021-2025

Information on how to identify strategic and tactical negotiation levels that will help achieve the best prices. Gain information on relevant pricing levels, detailed explanation on pros and cons of prevalent pricing models. Methods to help engage with the right suppliers and discover KPI's to evaluate incumbent suppliers. Insights into buyer strategies and tactical negotiation levers: Several strategic and tactical negotiation levers are explained in the report to help buyers achieve the best prices for the Pharma Clinical Trial Services market. The report also aids buyers with relevant Ph...

Steve Cutler: 'People understand what a clinical trial is now' - Vimarsana News

Steve Cutler: 'People understand what a clinical trial is now'

America will continue to be the focus. While Icon’s business is currently split evenly between the US and Europe (with the rest of the world accounting for 20 per cent), around two-thirds of all mandates come from US pharma companies. That reality is reflected in the fact that Cutler, like his predecessor Ciaran Murray is largely based over there. However, the acquisition will double Icon’s resources in the important Japanese market and in China. Where Icon previously had strategic partnerships – arrangements that deliver substantial work and revenues – with 40 per cent of...

Clinical Trial Imaging Services Market to Reach $1.80 Bn, Globally, by 2027 at 5.6% CAGR: Allied Market Research - Vimarsana News

Clinical Trial Imaging Services Market to Reach $1.80 Bn, Globally, by 2027 at 5.6% CAGR: Allied Market Research

by Service Type (Clinical Trial Design & Consultation Services, Reading & Analytical Services, Operational Imaging Services, Project & Data Management Services, and Others), End User (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, and Academic & Government Research Institutes), and Therapeutic Area (Oncology, Neurology, Endocrinology, Cardiology, Gastroenterology, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027." According to the report, the global clinical trial imaging services industry garnered $1.31 billion in 2019, and is expected to ...

Global $66.1 Billion Healthcare Contract Research Organization Market to 2028: Growing Pressure on Industry Players to Follow Stringent Timelines has Increased Demand - Vimarsana News

Global $66.1 Billion Healthcare Contract Research Organization Market to 2028: Growing Pressure on Industry Players to Follow Stringent Timelines has Increased Demand

The global healthcare contract research organization market size is expected to reach USD 66.1 billion by 2028 It is expected to expand at a CAGR of 6.6% from 2021 to 2028. The increasing cost of drug development is expected to drive the market over the forecast period. Moreover, rising clinical trial cost and challenges pertaining to patient recruitment have led biopharmaceutical companies to turn to regions like Central and Eastern Europe, Asia Pacific, Latin America, and the Middle East for cost savings and quick patient recruitment. In addition, growing pressure on industry players to fol...